<DOC>
	<DOC>NCT01061203</DOC>
	<brief_summary>Investigation of the effect of Grazax (grass tablet) on asthma prevention in children with grass pollen allergy</brief_summary>
	<brief_title>Grazax Asthma Prevention</brief_title>
	<detailed_description>Investigation of the effect of Grazax (ALK produced grass tablet) on asthma prevention in children with grass pollen allergy. Children in the age of 6-12 years will be randomised to either placebo or Grazax treatment. Grazax has been approved for treatment of grass pollen allergy in adults and children, diagnosed with a positive skin prick test and/or specific immunoglobulin (IgE) test to grass pollen and with clinically relevant symptoms. This study will explore prevention of asthma in children with grass pollen induced allergy.</detailed_description>
	<mesh_term>Rhinitis, Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<criteria>A history of grass pollen allergy Positive Skin prick test to grass Positive specific IgE to grass Asthma</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Rhinitis</keyword>
	<keyword>allergic</keyword>
	<keyword>Seasonal</keyword>
	<keyword>grass</keyword>
	<keyword>Asthma</keyword>
</DOC>